Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.

The alliance brings together Cellular Origins, a company focusing on applying robotics and other forms of automation to CGT ...